Current molecular aspects in the development and treatment of diabetes

Samuel Álvarez-Almazán, Jessica Georgina Filisola-Villaseñor, Diana Alemán-González-Duhart, Feliciano Tamay-Cach, Jessica Elena Mendieta-Wejebe

Resultado de la investigación: Contribución a una revistaReseña científicarevisión exhaustiva

1 Cita (Scopus)


© 2020, University of Navarra. Diabetes mellitus (DM) leads to microvascular, macrovascular, and neurological complications. Less is understood about the mechanisms of this disease that give rise to weak bones. The many molecular mechanisms proposed to explain the damage caused by chronic hyperglycemia are organ and tissue dependent. Since all the different treatments for DM involve therapeutic activity combined with side effects and each patient represents a unique condition, there is no generalized therapy. The alterations stemming from hyperglycemia affect metabolism, osmotic pressure, oxidative stress, and inflammation. In part, hemodynamic modifications are linked to the osmotic potential of the excess of carbohydrates implicated in the disease. The change in osmotic balance increases as the disease progresses because hyperglycemia becomes chronic. The aim of the current contribution is to provide an updated overview of the molecular mechanisms that participate in the development and treatment of diabetes.
Idioma originalInglés estadounidense
Páginas (desde-hasta)13-35
Número de páginas23
PublicaciónJournal of Physiology and Biochemistry
EstadoPublicada - 1 feb 2020


Profundice en los temas de investigación de 'Current molecular aspects in the development and treatment of diabetes'. En conjunto forman una huella única.

Citar esto